Doravirine (Pifeltro®) recommended as an option for use within NHS Wales

An option for use within NHS Wales, in combination with other antiretroviral products, for the treatment of adults infected with HIV-1 without past or present evidence of resistance to the NNRTI class.

All Wales Medicines Strategy Group